Search Results

A mix-method approach to understand clinician use of biomarker testing for patients with non-small cell lung cancer.

As precision medicine becomes more common in the management of lung cancer, little is understood about the patient experience with biomarker testing, particularly of underserved patients. This study used survey and focus group methodology to determine patient perspectives on the educational needs within this community.